Hellenic Journal of Surgery

, Volume 86, Issue 3, pp 155–158 | Cite as

Syringocystadenoma papilliferum on the breast: An unusual location

  • Arghya BasuEmail author
  • Dawood Khan
  • Sukumar Maiti
  • Soumika Biswas
Case Report



Syringocystadenoma papilliferum (SCAP), otherwise known as naevus syringocystadenomatosus papilliferus, is a skin hamartoma originating from apocrine or exocrine sweat glands [1], microscopically characterized by papillary invaginations lined by bi-layered epithelium and decapitation secretion rich in plasmacytes [3].

Case Report

A 29-year-old female presented with a cluster of large fleshy, irregular, sessile, moist, pinkish tumours located over her left breast, with pain, itching, discharge and bleeding upon friction with undergarments.


SCAP is an uncommon skin tumour usually seen in children or adolescents as a firm plaque of skincoloured to pinkish-brown hairless grouped nodules or a solitary nodule. Verrucous, papillary, hyperkeratotic, fleshy transformations are often seen in puberty [4,5]. Uncommon sites, such as the buttock, vulva, scrotum, pinna, eyelid, outer ear canal, postoperative scar, thigh, axilla, arms, lower limb, inguinal and perineal regions, have also been reported [6–9].


SCAP is a rare adnexal tumour commonly arising in association with congenital Sebaceous Naevus of Jadassohn. A watchful alertness is mandatory as adulthood malignancies can occur in more than one-third of this deceptively docile tumour.

Key words

Syringocystadenomatosus papilliferus breast tumour hamartoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Katoulis AC, Bozi E. Syringocystadenoma papilliferum. Orphanet Encyclopedia. 2004Google Scholar
  2. 2.
    Pinkus H. Life history of naevus syringocystadenomatous papilliferus. Arch Dermatol Syphil 1954; 69:305–322CrossRefGoogle Scholar
  3. 3.
    Bondi R, Urso C. Syringocystadenoma papilliferum. Histopathology 1996; 28:475–477PubMedCrossRefGoogle Scholar
  4. 4.
    Mammino JJ, Vidmar DA. Syringocystadenoma papilliferum. Int J Dermatol 1991; 30:763–766PubMedCrossRefGoogle Scholar
  5. 5.
    Karg E, Korom I, Varga E, Ban G, Turi S. Congenital Syringocystadenoma papilliferum. Pediatr Dermatol 2008; 25:132–133PubMedCrossRefGoogle Scholar
  6. 6.
    Rammeh-Rommani S, Fezaa B, Chelbi E, Kammoun MR, et al. Syringocystadenoma papilliferum: report of 8 cases. Pathologica 2006; 98:178–180PubMedGoogle Scholar
  7. 7.
    Ghosh SK, Bandyopadhyay D, Chatterjee G, Bar C. Syringocystadenoma papilliferum: an unusual presentation. Pediatr Dermatol 2009; 26:758–759PubMedCrossRefGoogle Scholar
  8. 8.
    Yap FB, Lee BR, Baba R. Syringocystadenoma papilliferum in an unusual location beyond the head and neck region: a case report and review of literature. Dermatol Online J 2010; 16:4PubMedGoogle Scholar
  9. 9.
    Premlatha S, Rao NR, Yesudian P, Razack A, Zahra A. Segmental syringocystadenoma papilliferum in an unusual location. Int J Dermatol 1985; 24:520–521CrossRefGoogle Scholar
  10. 10.
    Lin WL, Lin WC, Kuo TT, Chen CH, Hong HS. An unusual complex cutaneous adnexal tumour composed of Syringocystadenoma papilliferum, apocrine hidrocystoma and clear cell syringoma. Dermatol Surg 2007; 33:876–889PubMedGoogle Scholar
  11. 11.
    Arai Y, Kusakabe H, Kiyokane K. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in Syringocystadenoma papilliferum. J Dermatol 2003; 30:146–150PubMedCrossRefGoogle Scholar
  12. 12.
    Diaz RC, Babu SC. Ductal carcinoma arising from Syringocystadenoma papilliferum in the external auditory canal. Otol Neurotol 2007; 28:873–874PubMedCrossRefGoogle Scholar
  13. 13.
    Niizuma K. Syringocystadenoma papilliferum: light and electron microscopic studies. Acta Derm Venereol 1976; 56:327–336PubMedGoogle Scholar
  14. 14.
    Helwig EB, Hackney VC. Syringocystadenoma papilliferum. Arch Dermatol 1955; 71:361–372CrossRefGoogle Scholar
  15. 15.
    Yamamoto O, Doi Y, Hamada T, Hisaoka M, Sasaguri Y. An immunohistochemical and ultrastructural study of Syringocystadenoma papilliferum. Br J Dermatol 2002; 147:936–945PubMedCrossRefGoogle Scholar
  16. 16.
    Mazoujian G, Margolis R. Immunohistochemistry of gross cystic disease fluid protein (GCDFP — 15) in 65 benign sweat gland tumours of the skin. Am J Dermatopathol 1988; 10:28–35PubMedCrossRefGoogle Scholar
  17. 17.
    Ishida-Yamamoto A, Sato K, Wada T, et al. Syringocystadenoma papilliferum: case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol 2001; 45:755–759PubMedCrossRefGoogle Scholar
  18. 18.
    Chi CC, Tsai RY, Wang SH. Syringocystadenoma papilliferum: successfully treated with Moh’s micrographic surgery. Dermatol Surg 2004; 30:468–471PubMedGoogle Scholar

Copyright information

© Hellenic Surgical Society and Springer-Verlag Wien 2014

Authors and Affiliations

  • Arghya Basu
    • 1
    • 3
    Email author
  • Dawood Khan
    • 1
  • Sukumar Maiti
    • 1
  • Soumika Biswas
    • 2
  1. 1.Department of General SurgeryMedical College and HospitalKolkataIndia
  2. 2.Department of BiochemistryMedical College and HospitalKolkataIndia
  3. 3.West BengalIndia

Personalised recommendations